Initially , patients were randomly assigned to receive either pemetrexed ( @ mg/m ( @ ) ) or docetaxel ( @ mg/m ( @ ) ) and then randomly assigned within each group to receive their chemotherapy with or without cetuximab ( @ mg/m ( @ ) at first dose and @ mg/m ( @ ) weekly thereafter ) until disease progression or unacceptable toxicity .